Companies: 10,795·Total market cap: $144.5T
USANA Health Sciences, Inc.

USANA Health Sciences, Inc.

USNANYSEConsumer Defensive● Active
$18.61
+$0.58(+3.19%)
Market Cap$343504320
P/E Ratio
52W High$38.32
52W Low$16.6

USANA Health Sciences, Inc. (USNA) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · USNA · as of Sep 30, 2025

Ownership Breakdown

Institutions 69.3%
Insiders 46.67%
Public 0%

167

Institutional Holders

▲ 1 vs Q2

$371.38M

Total Inst. Value

▲ $34.94M vs Q2

18.46M

Shares Outstanding

freeFloat 53.33%

12.79M

13F Shares Held

▲ 1.77M vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

USNA largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

BLACKROCK, INC.

medicinal chemicals & botanical products

1.80M9.70%

9.70%

$49.49BNov 12, 2025 2.9K

SUMMIT WEALTH GROUP LLC / CO

medicinal chemicals & botanical products

1.66M8.98%

8.98%

$64.65BFeb 5, 2026NEW

PZENA INVESTMENT MANAGEMENT LLC

medicinal chemicals & botanical products

1.21M6.55%

6.55%

$33.41BNov 7, 2025 14.3K

RENAISSANCE TECHNOLOGIES LLC

medicinal chemicals & botanical products

1.13M6.08%

6.08%

$31.01BNov 13, 2025 29.3K

VANGUARD GROUP INC

medicinal chemicals & botanical products

1.07M5.77%

5.77%

$29.45BNov 7, 2025 57.2K

DIMENSIONAL FUND ADVISORS LP

medicinal chemicals & botanical products

915.0K4.94%

4.94%

$25.21BNov 12, 2025 17.3K

STATE STREET CORP

medicinal chemicals & botanical products

427.5K2.31%

2.31%

$11.78BNov 14, 2025 1.1K

MORGAN STANLEY

medicinal chemicals & botanical products

327.1K1.77%

1.77%

$9.01BMay 27, 2026 2.5K

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

medicinal chemicals & botanical products

288.1K1.56%

1.56%

$7.94BNov 10, 2025 59.9K

JACOBS LEVY EQUITY MANAGEMENT, INC

medicinal chemicals & botanical products

265.0K1.43%

1.43%

$7.30BNov 17, 2025 85.6K

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBullish — more buying than selling

25

Increased

+816.2K shares

3

New Positions

first time holders

21

Decreased

−490.0K shares

0

Sold Out

fully exited

Net shares change (top 50)

+326.2K

+816.2K / −490.0K

Net new holders

+7

3 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

USNA insider trading · insider activity

Source: SEC Form 4

Buy 0%Active transactions only100% Sell

Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.

14

Buy transactions

15

Sell transactions

0.93

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

Fleming John Turman

director

Jun 1, 2026Sale2,450$17.93$43.9K4.2KForm 4 ↗

Jones Paul A.

CHIEF PEOPLE OFFICER

May 28, 2026Sale6,813$18.95$129.1K5.6KForm 4 ↗

IIEKKING G DOUG

CHIEF FINANCIAL OFFICER

May 27, 2026Sale5,360$18.75$100.5K0Form 4 ↗

FULLER GILBERT A

director

May 22, 2026Sale1,057$18.66$19.7K0Form 4 ↗

WOOD TIMOTHY E

director

May 7, 2026Award6,5276.5KForm 4 ↗

Nixon J Scott

director

May 7, 2026Award6,5276.5KForm 4 ↗

Pelosi Peggie

director

May 7, 2026Award6,5276.5KForm 4 ↗

Fleming John Turman

director

May 7, 2026Award6,5276.5KForm 4 ↗

Winssinger Frederic J

director

May 7, 2026Award6,5276.5KForm 4 ↗

FULLER GILBERT A

director

May 7, 2026Award6,5276.5KForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

USANA Health Sciences, Inc. (USNA) is primarily owned by institutional investors, who hold approximately 69.3% of total shares outstanding. Company insiders own approximately 46.67%, while retail and public investors account for the remaining 0.00%.

The largest institutional shareholder of USANA Health Sciences, Inc. is BLACKROCK, INC., holding approximately 1.80 million shares — equal to 9.70% of outstanding shares — as of September 30, 2025.

A total of 167 institutional investors currently hold USNA stock, with a combined institutional value of approximately $371,376,255 as of the most recent 13F filing period.

Frequently asked questions

USNA ownership

USANA Health Sciences, Inc. (USNA) is primarily owned by institutional investors, who hold approximately 69.3% of shares. The largest shareholder is BLACKROCK, INC. with a 9.70% stake. Company insiders hold 46.67%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns USNA stockUSNA ownership structureSEC Form 13F institutional holdingsUSNA float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025